MarketCap
Facebook
X
TelegramQuidel Corporation DIO Ratio 2011-2026 | QDEL
Annual DIO Ratio Quidel Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 133 | 99 | 119 | 201 | 129 | 134 | 122 | 151 | 92.3 | 85.1 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 201 | 85.1 | 127 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
97.1 | $ 116.09 | 0.48 % | $ 35.3 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
137 | $ 127.85 | -0.03 % | $ 20.3 B | USA |
 |
Co-Diagnostics
CODX
|
1.69 K | $ 1.65 | -1.2 % | $ 2.19 M | USA |
 |
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 84.13 | -0.24 % | $ 5.68 B | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 25.25 | 3.23 % | $ 701 M | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.49 | 0.07 % | $ 20 B |  Niderland |
 |
CareDx, Inc
CDNA
|
48.3 | $ 21.59 | 1.67 % | $ 1.15 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Senseonics Holdings
SENS
|
104 | $ 7.05 | -0.07 % | $ 294 M | USA |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Soleno Therapeutics
SLNO
|
1.02 K | $ 52.73 | 0.01 % | $ 2.68 B | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 16.04 | -1.67 % | $ 485 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Thermo Fisher Scientific
TMO
|
86.5 | $ 470.4 | 0.18 % | $ 177 B | USA |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Trinity Biotech plc
TRIB
|
212 | $ 0.65 | 0.18 % | $ 61.9 M |  Irlanda |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 172.63 | 1.68 % | $ 8.56 B | USA |
 |
Twist Bioscience Corporation
TWST
|
51.5 | $ 60.26 | -1.17 % | $ 3.6 B | USA |
 |
Guardant Health
GH
|
82.1 | $ 90.75 | 2.07 % | $ 11.4 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
29.1 | $ 2.0 | 1.27 % | $ 8.85 M | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K |  Israel |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
147 | $ 9.53 | -0.16 % | $ 2.07 B | USA |
 |
Biomerica
BMRA
|
147 | $ 2.16 | 0.93 % | $ 4.96 M | USA |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 101.26 | -0.89 % | $ 8.35 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 264.04 | 0.09 % | $ 22 B | USA |
 |
OpGen
OPGN
|
459 | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 8.49 | 2.35 % | $ 1.09 B | USA |
 |
Myriad Genetics
MYGN
|
42.8 | $ 4.77 | -0.21 % | $ 442 M | USA |
 |
Natera
NTRA
|
25.8 | $ 206.37 | 1.29 % | $ 20.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
9.34 | $ 197.48 | 0.62 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
87.6 | - | -0.91 % | $ 14.7 B | USA |